本総説は，日本薬学会第 129 年会シンポジウム GS5 で 発表したものを中心に記述したものである． We have previously found that antitussive drugs inhibit G protein-coupled inwardly rectifying potassium (GIRK) channel currents in brain neurons. Potassium eOEux through GIRK channels causes membrane hyperpolarization, and thus plays an important role in the inhibitory regulation of neuronal excitability. Because GIRK channels are coupled to various G protein-coupled receptors including monoamine receptors, antitussives are possible to aŠect the levels of various neurotransmitters in the brain. Many currently available antidepressants have been developed based on the monoamine theory for the etiology of depression. We hypothesized that new drugs such as tipepidine may lead to changes in the balance of monoamine levels in the brain resulting in improvement in symptoms of depression. Therefore, we investigated whether or not the drugs have antidepressant activity in the animal models. Male Wistar rats (200 240 g) were used. Tipepidine, cloperastine and caramiphen signiˆcantly reduced the immobility in forced swimming test (FST) using normal rats. All drugs had little eŠect on loco-motor activity. The eŠects on the forced swimming were inhibited by treatment with AMPT, but not PCPA. Tipepidine also inhibited hyperactivity in olfactory bulbectomized rats. Interestingly, tipepidine also signiˆcantly reduced the immobility in FST using ACTH-treated rats which is a model of depression resistant to treatment with antidepressants. Given these results together with cumulatedˆndings, it is suggested that tipepidine may have a novel antidepressant-like action, and that the eŠect may be caused at least partly through the action on the catecholaminergic system in the brain.
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